How to choose a biocompatible resin correctly

What are you trying to manufacture?

Rigid guides, surgical guides or rigid splints

Prioritize stiffness, dimensional stability and controlled workflow validation.

• Mechanical target: rigid, high modulus and low deformation.
• Typical route: Biorigid or rigid dental biocompatible systems.
• If lower reactive residual profile is preferred: prioritize Monomer Free (MF) grades where available.

Typical examples: rigid night guards, surgical guides, rigid dental structures and high-stability biomedical parts.

Denture bases, crowns, bridges or rigid dental structures

Prioritize fit, rigidity, color workflow compatibility and validated post-curing.

• Mechanical target: rigid or tough rigid.
• Typical route: rigid dental biocompatible systems and high-strength dental families.
• For higher extractables control: prioritize MF grades where available.

Critical variables: geometry, thickness, colored workflow, post-curing depth and final finishing.

Aligners, foldable appliances or comfort-driven dental parts

Prioritize toughness, controlled flexibility and repeatable laboratory processing.

• Mechanical target: tough semi-rigid or foldable behaviour.
• Typical route: Biotough D70-D80 or dedicated dental aligner / foldable families.
• If comfort and insertion matter: avoid choosing only by hardness label.

Critical variables: thermoforming interaction, geometry, surface quality, polishing and post-curing consistency.

Flexible, soft or elastic biomedical parts

Prioritize controlled deformation, recovery, comfort and application-specific exposure conditions.

• Mechanical target: semi-rigid, flexible, soft or elastic behaviour.
• Typical route: Bioflex or BioElastic systems.
• If prolonged exposure risk matters: prioritize lower-risk formulation routes and strict workflow control.

This route is often more sensitive to post-curing, residual species mobility and extractables behaviour.

Models, non-implantable lab parts or reference parts

Do not assume biocompatible materials are always the correct choice. In many cases, a non-biocompatible but better-adapted engineering or dental model resin may be more appropriate.

• Mechanical target: dimensional accuracy and workflow efficiency.
• Typical route: dental models, engineering reference materials or standard controlled photopolymers.
• Decision rule: use biocompatible systems only where biological interaction or downstream validation requires them.

This route prevents over-specification and avoids using biomedical materials where they do not add real value.

Monomer Free (MF) or Monomer Based (MB)?

• Choose MF when reduced reactive residual species and improved control of extractables are strategic priorities.
• Choose MB when a wider material range is acceptable and the workflow can be tightly validated and controlled.
• Do not interpret MF as automatic safety. MF improves the starting chemical strategy, but does not replace post-processing, validation or application-specific testing.

Can your workflow control conversion, residuals and post-processing?

• Is the printer optically stable and compatible with the selected resin?
• Are exposure parameters calibrated rather than copied from generic settings?
• Is washing effective, reproducible and appropriate for the geometry?
• Is post-curing validated for thickness, transparency and part complexity?
• Can you document lot, printer, wash and cure conditions for repeatability?

If the answer is no, resin selection is premature. Process capability comes before any safety or performance claim.

Polymer conversion is a limiting factor

In photopolymer additive manufacturing, polymer conversion is never complete. Even under optimized conditions, residual monomers, oligomers and reaction by-products may remain within printed parts.

This directly affects extractables, surface chemistry and biological response, making conversion control a critical parameter in biocompatible material selection.

• conversion depends on exposure conditions, geometry and optical penetration
• internal regions may exhibit lower conversion than external surfaces
• post-curing strategy directly influences final conversion level
• higher conversion does not automatically eliminate extractables

Material selection must therefore be aligned with the achievable conversion within the specific workflow, not assumed from datasheet values or nominal curing conditions.

Extractables and leachables define real exposure risk

In biocompatible photopolymer workflows, the key question is not only how much the material cures, but what residual species may remain and under which conditions they may be released.

Extractables and leachables depend on formulation design, degree of conversion, geometry, post-processing efficiency and the real exposure environment of the final part.

• residual species may remain trapped within the polymer network after printing and post-curing
• complex geometries and thick sections may retain higher internal residual fractions
• cleaning, drying and post-curing strongly influence the final extractables profile
• biological response depends on what can actually migrate or be extracted under use conditions

Material selection must therefore consider not only mechanical behaviour and nominal biocompatibility positioning, but also the capacity of the workflow to control residual species and reduce extractable-related risk.

Incorrect selection logic

• Choosing only by certification or brand label.
• Choosing only by Shore hardness without understanding structural behaviour.
• Ignoring geometry, thickness and curing limitations.
• Assuming polymer conversion automatically defines safety.
• Using biocompatible materials where only dimensional models are required.
• Skipping workflow validation because the resin is marketed as biocompatible.

Explore material systems designed for controlled workflows